Skip to main content

Advertisement

Log in

Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

A Publisher Correction to this article was published on 22 August 2022

This article has been updated

Abstract  

With the rise in obesity and bariatric procedures worldwide, there has been a surge in new and innovative procedures that has been increasingly offered to patients. In this position statement, IFSO highlights the importance of surgical ethics in innovation and when offering new procedures. Furthermore, the task force reviewed the current literature to describe which procedures can be offered as mainstream outside research protocols versus those that are still investigational and need further data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Change history

References 

  1. Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31(5):1937–1948. https://doi.org/10.1007/s11695-020-05207-7.

  2. Cardenas D. Surgical ethics: a framework for surgeons, patients, and society. Rev Col Bras Cir. 2020;15(47):e20202519. https://doi.org/10.1590/0100-6991e-20202519.

    Article  Google Scholar 

  3. Angelos P. Ethics and surgical innovation: challenges to the professionalism of surgeons. Int J Surg. 2013;11(Suppl 1):S2-5. https://doi.org/10.1016/S1743-9191(13)60003-5.

    Article  PubMed  Google Scholar 

  4. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. Ethical Principles and Guidelines for the Protection of Human subjects or Research. https://www.hhs.gov/ohrp/regulations-and-policy.

  5. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.

  6. Levine RJ. New international ethical guidelines for research involving human subjects. Ann Intern Med. 1993;119:340–51.

    Article  Google Scholar 

  7. Health & Medicine, Technology, Business, Oct 25, 2011

  8. Enfield KB, Truwit JD. The purpose, composition, and function of an institutional review board: balancing priorities. Respir Care. 2008;53(10):1330–6.

    PubMed  Google Scholar 

  9. Lapid MI, Clarke BL, Wright RS. Institutional Review Boards: what clinician researchers need to know. Mayo Clin Proc. 2019;94(3):515–25. https://doi.org/10.1016/j.mayocp.2019.01.020.

    Article  PubMed  Google Scholar 

  10. Blenkinsopp A. From compliance to concordance: how are we doing? Int J Pharm Pract. 2001;9:65–6.

    Article  Google Scholar 

  11. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651–61.

    Article  CAS  Google Scholar 

  12. Raper SE, Sarwer DB. Informed consent issues in the conduct of bariatric surgery. Surg Obes Relat Dis. 2008;4(1):60–8.

    Article  Google Scholar 

  13. Wee Ch C, Pratt JS. Fanelli R, Samour PQ, Trainor LS, Paasche‐Orlow MK. Best practice updates for informed consent and patient education in weight loss surgery. Obesity. 2012;17(5): 885–888

  14. Kaufman AS, McNelis J, Slevin M, La Marca C. Bariatric surgery claims—a medico-legal perspective. Obes Surg. 2006;16:1555–8.

    Article  Google Scholar 

  15. Heerman WJ, White RO, Barkin SL. Advancing informed consent for vulnerable populations. Pediatrics. 2015;135(3):e562–4. https://doi.org/10.1542/peds.2014-3041.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Weithorn LA, Campbell SB. The competency of children and adolescents to make informed treatment decisions. Child Dev. 1982;53:1589–98.

    Article  CAS  Google Scholar 

  17. Kuther TL, Posada M. Children and adolescents' capacity to provide informed consent for participation in research. Adv Psychol Res. 2004;32:163–173. https://www.surgeons.org/about-racs/positionpapers/interactions_with_the_medical_industry_2017.

  18. Royal Australasian College of Surgeons, Australian Safety and Efficacy Register of New Interventional Procedures – Surgical.

  19. The Practice Committee of the American Society for Reproductive Medicine. Definition of "experimental procedures. Fertil Steril. 2009;92(5):1517.

  20. Ashton CM, Wray NP, Jarman AF, Kolman JM, Wenner DM, Brody BA. Ethics and methods in surgical trials. J Med Ethics. 2009;35(9):579–83. https://doi.org/10.1136/jme.2008.028175.

    Article  CAS  PubMed  Google Scholar 

  21. McCambridge J, Sorhaindo A, Quirk A, Nanchahal K. Patient preferences and performance bias in a weight-loss trial with a usual care arm. Patient Educ Couns. 2014;95(2):243–7. https://doi.org/10.1016/j.pec.2014.01.003.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Broekman ML, Carrière ME, Bredenoord AL. Surgical innovation: the ethical agenda: a systematic review. Medicine (Baltimore). 2016;95(25):e3790. https://doi.org/10.1097/MD.0000000000003790.

    Article  Google Scholar 

  23. Halverson JD, Wise L, Wazna MF, Ballinger WF. Jejunoileal bypass for morbid obesity. A critical appraisal Am J Med. 1978;64:461–75.

    CAS  PubMed  Google Scholar 

  24. Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186(4):500–9.

    Article  Google Scholar 

  25. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47(6):1345–51.

    Article  CAS  Google Scholar 

  26. Abu Dayyeh BK, Edmundowicz S, Thompson CC. Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies. Gastroenterology. 2017;152(4):716–29.

    Article  Google Scholar 

  27. Brown W.A., Ponce de Leon-Ballesteros G., Ooi G., Higa K., Himpens J., Torres A., Shikora S., Kow L., Herrera M.F. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS). IFSO Position Statement—Update 2020. Obes Surg. 2021.

  28. Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial [published correction appears in Lancet. 2019 Mar 30;393(10178):1298]. Lancet. 2019;393(10178):1299–1309. https://doi.org/10.1016/S0140-6736(19)30475-1

  29. De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28(5):1188–206.

    Article  Google Scholar 

  30. De Luca M, Piatto G, Merola G, et al. IFSO update position statement on one anastomosis gastric bypass (OAGB). Obes Surg. 2021;31(7):3251–78. https://doi.org/10.1007/s11695-021-05413-x.

    Article  PubMed  Google Scholar 

  31. Aleman R, Lo Menzo E, Szomstein S, Rosenthal RJ. Efficiency and risks of one-anastomosis gastric bypass. Ann Transl Med. 2020;8(Suppl 1):S7. https://doi.org/10.21037/atm.2020.02.03.

    Article  PubMed  PubMed Central  Google Scholar 

  32. da Silva LE, Alves MM, El-Ajouz TK, Ribeiro PC, Cruz RJ Jr. Laparoscopic Sleeve-Collis-Nissen Gastroplasty: a Safe Alternative for Morbidly Obese Patients with Gastroesophageal Reflux Disease. Obes Surg. 2015;25(7):1217–22. https://doi.org/10.1007/s11695-014-1523-4.

    Article  PubMed  Google Scholar 

  33. Del Genio G, Tolone S, Gambardella C, Brusciano L, Volpe ML, Gualtieri G, Del Genio F, Docimo L. Sleeve gastrectomy and anterior fundoplication (D-SLEEVE) prevents gastroesophageal reflux in symptomatic GERD. Obes Surg. 2020 May;30(5):1642–52. https://doi.org/10.1007/s11695-020-04427-1 Erratum In: Obes Surg. 2021;31(4):1902.

  34. Crawford C, Gibbens K, Lomelin D, Krause C, Simorov A, Oleynikov D. Sleeve gastrectomy and anti-reflux procedures. Surg Endosc. 2017 Mar;31(3):1012–21. https://doi.org/10.1007/s00464-016-5092-6.

    Article  PubMed  Google Scholar 

  35. Aiolfi A, Micheletto G, Marin J, Rausa E, Bonitta G, Bona D. Laparoscopic sleeve-fundoplication for morbidly obese patients with gastroesophageal reflux: systematic review and meta-analysis. Obes Surg. 2021;31(4):1714–1721. https://doi.org/10.1007/s11695-020-05189-6.

  36. Carandina S, Zulian V, Nedelcu A, Danan M, Vilallonga R, Nocca D, Nedelcu M. Is it safe to combine a fundoplication to sleeve gastrectomy? Review of literature. Medicina (Kaunas). 2021;57(4):392. https://doi.org/10.3390/medicina57040392.

    Article  Google Scholar 

  37. Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis. 2013;9(3):398–403. https://doi.org/10.1016/j.soard.2011.08.019.

  38. Lee WJ, Han ML, Ser KH, Tsou JJ, Chen JC, Lin CH. Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results. Obes Surg. 2014;24(9):1447–52. https://doi.org/10.1007/s11695-014-1223-0.

    Article  PubMed  Google Scholar 

  39. Talha A, Ibrahim M. Laparoscopic Nissen fundoplication plus mid-gastric plication for treatment of obese patients with gastroesophageal reflux disease. Obes Surg. 2018;28(2):437–43. https://doi.org/10.1007/s11695-017-2862-8.

    Article  PubMed  Google Scholar 

  40. Ospanov O, Maleckas A, Orekeshova A. Gastric greater curvature plication combined

  41. with Nissen fundoplication in treating gastroesophageal reflux disease and obesity. Medicina (Kaunas). 2016;52(5):283–290. https://doi.org/10.1016/j.medici.2016.08.001.

  42. Ivano FH, Mesquita LP, Simamura CM, Kuwaki GM, Colman JT, Campos GM. Pre and postoperative pH monitoring and weight loss analysis in patients undergoing gastric plication in association with fundoplication. Arq Bras Cir Dig. 2017;30(4):244–247. https://doi.org/10.1590/0102-6720201700040004.

  43. Herron DM. Comment on: fundoplication combined to a medio-gastric plication. Surg Obes Relat Dis. 2013;9(3):403–4. https://doi.org/10.1016/j.soard.2011.09.001.

  44. Santoro S, Castro LC, Velhote MCP, Malzoni CE, Klajner S, Castro LP, Lacombe A, Santo MA, Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104–10.

    Article  Google Scholar 

  45. Belicik T. Metabolic effects of sleeve gastrectomy with transit bipartition in obese females with type 2 diabetes mellitus: results after 1 year follow-up. Obes Surg. 2019;29:805–10.

    Article  Google Scholar 

  46. Mui WL-M, Lee DW-H, Lam KK-Y. Laparoscopic sleeve gastrectomy with loop bipartition: a novel metabolic operation in treating obese type II diabetes mellitus. Int J Surg Case Rep. 2014;5:56–8.

    Article  Google Scholar 

  47. Mahdy A, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28–34.

    Article  CAS  Google Scholar 

  48. Mahdy T, Gado W, Alwahidi A, Schou C, Emile SH. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg. 2021;31:1579–89.

    Article  Google Scholar 

  49. Emile SH, Mahdy T, Schou C, Kramer M, Shikora S. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity with proportion meta-analysis of improvement in diabetes mellitus. Int J Surg. 2021;92:104–10.

    Article  Google Scholar 

  50. Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodeno-jejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341–5.

    Article  Google Scholar 

  51. Seki Y, Kasama K, Umezawa A, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for type 2 diabetes mellitus. Obes Surg. 2016;26(9):2035–44.

    Article  Google Scholar 

  52. Seki Y, Kasama K, haruta H, Watanabe A, Yokoyama R. et al. Five-year-results of laparoscopic sleeve gastrectomy with duodenojejunal bypass for weight loss and type 2 diabetes mellitus. Obes Surg. 2017;3:795–801. https://doi.org/10.1007/s11695-016-2372-0.

  53. Praveen Raj P, Kumaravel R, Chandramaliteeswaran C, Rajpandian S, Palanivelu C. Is laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux En Y gastric bypass in morbidly obese patients: preliminary results of a randomized trial. Obes Surgery. 2012;22:422–6.

    Article  CAS  Google Scholar 

  54. Lee WJ, Almulaifi AM, Tsou J-J, Ser K-H, Lee Y-C, Chen S-C. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70.

    Article  Google Scholar 

  55. Naitoh T, Kasama K, Seki Y, et al. Efficacy of sleeve gastrectomy with duodenal-jejunal bypass for treating obese severe diabetes patients in Japan: a retrospective multicenter study. Obes Surg. 2018;28(2):497–505.

    Article  Google Scholar 

  56. Melissas J, Peppe A, Askoxilakis J, Dimitriadis E, Grammatikakis J. Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg. 2012;22(7):1104–9. https://doi.org/10.1007/s11695-012-0637-9.

    Article  PubMed  Google Scholar 

  57. Hassn A, Luhmann A, Rahmani S, Morris-Stiff G. Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg. 2016;26(10):2316–23. https://doi.org/10.1007/s11695-016-2098-z.

    Article  PubMed  Google Scholar 

  58. Singh D, Laya AS, Clarkston WK, Allen MJ. Jejunoileal bypass: a surgery of the past and a review of its complications. World J Gastroenterol. 2009;15(18):2277–9. https://doi.org/10.3748/wjg.15.2277.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Cohen R, Caravatto PP, Petry T. Metabolic surgery for type 2 diabetes in patients with a BMI of <35 kg/m(2): A Surgeon’s Perspective. Obes Surg. 2013;23(6):809–18. https://doi.org/10.1007/s11695-013-0930-2.

    Article  PubMed  Google Scholar 

  60. DePaula AL, Macedo AL, Mota BR, Schraibman V. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29. Surg Endosc. 2009;23(6):1313–20. https://doi.org/10.1007/s00464-008-0156-x.

    Article  CAS  PubMed  Google Scholar 

  61. Celik A, Ugale S, Ofluoglu H, Asci M, Celik BO, Vural E, Aydin M. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25(7):1184–90. https://doi.org/10.1007/s11695-014-1518-1

    Article  PubMed  Google Scholar 

  62. Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238–44. https://doi.org/10.1007/s00268-011-1188-2.

    Article  PubMed  Google Scholar 

  63. de Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal Interposition ("neuroendocrine brake")--pilot study of a new operation. Surg Obes Relat Dis. 2006;2(4):464–7. https://doi.org/10.1016/j.soard.2006.03.005.

  64. Celik A, Cagiltay E, Ugale S, Asci M, Celik BO, Karaca C, Abdul-Ghani M. Diverted sleeve gastrectomy with ileal transposition in overweight, obese, and morbidly obese patients with type 2 diabetes: results of 1-year follow-up. Surg Obes Relat Dis. 2016;12(3):541–549. https://doi.org/10.1016/j.soard.2015.09.027.

  65. Inabnet WB. Comment on: prospective randomized controlled trial comparing 2 versions of laparoscopic ileal Interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m(2). Surg Obes Relat Dis. 2010;6(3):304–5. https://doi.org/10.1016/j.soard.2009.11.005.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ashraf Haddad.

Ethics declarations

Informed Consent

For this type of study, formal consent is not required.

Conflict of Interest

Miguel Herrera and Lilian Kow do not have any conflict of interests. Ashraf Haddad is a speaker for Medtronic and EZsurg medical. Ricardo V Cohen reports Research Grant, Johnson&Johnson, Research Grant Medtronic, Research Grant, GI Dynamics. Speaker Johnson&Johnson, Medtronic, GI Dynamics, Jansen. SAB: GI Dynamics, NovoNordisk, Bariatek. Scott Shikora is the Editor-in-Chief of Obesity Surgery Journal.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haddad, A., Kow, L., Herrera, M.F. et al. Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement. OBES SURG 32, 3217–3230 (2022). https://doi.org/10.1007/s11695-022-06220-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-022-06220-8

Keywords

Navigation